论文部分内容阅读
2014年7月,人体再生复原科学世界知识产权发展进程中再获喜讯,再生生命科学创立人徐荣祥再获欧洲专利——药物组合物在制备治疗糖尿病溃疡药物中的用途,该项专利的获得意味着人体再生复原科学在损伤器官再生领域的又一世界性推进成果。截至目前为止,徐荣祥教授已获得国内外专利共30项。糖尿病溃疡是当今世界的治疗难题,目前仍缺乏简便有效的治疗方法,其感染率高、截肢率高、创面愈合困难等难题一直困扰着世界医学领域,而临床上常用的外科植皮封闭创面疗法则风险大、
In July 2014, the human body reborn in the scientific world of intellectual property re-won the good news in the process of rebuilding, Xu Rongxiang, founder of life sciences re-won the European patent - the use of pharmaceutical composition in the preparation of drugs for the treatment of diabetic ulcers, the patent means Human regeneration and restoration of science in the field of damaged organs in the field of another global promotion of results. So far, Professor Xu Rongxiang has won a total of 30 domestic and foreign patents. Diabetic ulcer is a difficult problem in the world today. Currently, there is still a lack of simple and effective treatment methods. The problems such as high infection rate, high amputation rate and difficult wound healing have plagued the world medical field. However, the clinically common surgical skin graft closed wound therapy Risky,